Deciphera Pharmaceuticals Inc (NASDAQ:DCPH)
| 16.40 Delayed Data As of Aug 12 |  +0.64 / +4.06%Today’s Change | 6.51 Today|||52-Week Range 37.99 | +67.86% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | Quarter 2 2019 | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 0.00 | 25.0M | |
| Depreciation And Amortization | 88.0K | 99.0K | 104.0K | 112.0K | ||
| Operating Expenses | Gross Income | -88.0K | -99.0K | -104.0K | -- | |
| General Expenses | 25.8M | 33.7M | 48.9M | 47.9M | ||
| Research And Development | 20.6M | 27.4M | 35.8M | 34.8M | ||
| Total Operating Expenses | 25.9M | 33.8M | 49.0M | 48.0M | ||
| Non-Operating Expenses | Operating Income | -25.9M | -33.8M | -49.0M | -23.0M | |
| Interest Expense On Debt | 21.0K | 20.0K | 13.0K | 25.0K | ||
| Other Expenses | 1.5M | 1.6M | 1.7M | 1.5M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -24.4M | -32.3M | -47.4M | -21.5M | |
| Net Income | -24.4M | -32.3M | -47.4M | -21.5M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 37.7M | 37.7M | 38.1M | 38.2M | |
| Shares To Calculate EPS Diluted | 37.7M | 37.7M | 38.1M | 38.2M | ||
| Earnings Per Share | EPS | -$0.65 | -$0.86 | -$1.25 | -$0.56 | |
| EPS Diluted | -$0.65 | -$0.86 | -$1.25 | -$0.56 | ||
